OBJECTIVE: There are no studies on the prevalence of celiac disease (CD) in
either Brazil or, as far as we know, South America. The aim of this study
was to determine the prevalence of CD in healthy blood donors in the city o
f Brasilia, Brazil.
METHODS: Sera were obtained, independently of age and gender, from an unsel
ected group of 2045 blood donors attending the Hematological Center of Bras
ilia. An IgG antigliadin antibody (AGA) test was used as a first-level scre
ening step, followed by IgA-AGA test, serum IgA antiendomysium (EMA), and t
otal serum IgA determination performed in all sera showing abnormally high
IgG-AGA results. Jejunal biopsy was suggested for all subjects showing at l
east one of the following: IgA-EMA positivity; IgG-AGA and IgA-AGA positivi
ty; IgG-AGA positivity and selective IgA deficiency. AGA was determined by
an enzyme-linked immunosorbent assay (ELISA) technique and IgA-EMA was asce
rtained by indirect immunofluorescence on cryostat sections of monkey esoph
agus. Jejunal mucosa samples were obtained with a Watson capsule.
RESULTS: Sixty-two (3.03%) blood donors had IgG-AGA above the cut-off value
s. Fifty-eight individuals showed isolated high values of IgG-AGA, whereas
four had simultaneously increased IgG and IgA-AGA. Three patients had posit
ive IgA-EMA test (one with both IgG- and IgA-AGA and two with only IgG-AGA)
and underwent jejunal biopsies that disclosed complete villous atrophy ass
ociated with an increased number of intraepithelial lymphocytes and hypertr
ophic criptae. In this study group, the prevalence of biopsy-proven celiac
disease was 1.47 +/- 1.66 in 1000 subjects.
CONCLUSIONS: We found a prevalence of undiagnosed CD of 1:681 among apparen
tly healthy blood donors. These preliminary results support the view that C
D is not a rare disease in Brazil. (Am J Gastroenterol 2000;95:689-692. (C)
2000 by Am. Cell. of Gastroenterology).